Alumis ALMS
NASDAQ ALMS
$7.29 +0.13 (+1.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

Alumis (ALMS) EBITDA (2023 - 2025)

Updated

Alumis (ALMS) recorded EBITDA of -$95.58 million in Q4 2025, compared with -$97.8 million a year earlier.

Analysis

Alumis (ALMS) EBITDA (2023 - 2025) Analysis & Trends

For FY2025, Alumis reported EBITDA of -$450.31 million.

  • Across earlier years, EBITDA came in at -$297.6 million in FY2024 and -$156.89 million in FY2023.
  • The Q4 2025 figure is the highest quarterly EBITDA since Q2 2024.
  • Per Business Quant, the preceding three quarters came in at -$114.38 million (Q3 2025), -$139.67 million (Q2 2025) and -$100.69 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Alumis 891.03 Mn -783.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -95.58 Mn
Sep 30, 2025 -114.38 Mn
Jun 30, 2025 -139.67 Mn
Mar 31, 2025 -100.69 Mn
Dec 31, 2024 -97.80 Mn
Sep 30, 2024 -97.59 Mn
Jun 30, 2024 -55.38 Mn
Mar 31, 2024 -46.84 Mn
Dec 31, 2023 -39.41 Mn
Sep 30, 2023 -43.44 Mn
API Access

Alumis EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ALMS&period=max&api_key=YOUR_API_KEY